title: Antisense gene therapy for neurodegenerative disease?
abstract: Diseases resulting from defects in a single gene may be more amenable to treatment by conventional gene therapy strategies than idiopathic or polygenic disorders. We have attempted to reduce the expression in vivo of the Huntington's disease gene protein, Huntingtin, using an 18-mer fluorescein-labeled phosphorothiorated antisense oligodeoxynucleotide (ODN) targeted against the start site of the first exon of the IT15 gene. Animals were given repeated intrastriatal infusions (5 microliters of a 100 nmol/microliter solution daily over 4 days) of the antisense ODN. The treatments ended on Day 5 and the tissue was processed for immunohistochemical and Western blot analysis. The fluorescein-labeled ODN appeared to penetrate several cells and did not cause any obvious toxicity to the neurons. The average reduction in levels of Huntingtin (16.9 +/- 7.2%) did not differ significantly between striatal tissue of antisense ODN-treated animals compared to those treated with a sense ODN or vehicle. Improved methods for molecular modifications of the IT15 gene may be needed for therapeutic initiatives.
authors.affiliation: Neuroregeneration Laboratory, Harvard Medical School/McLean Hospital, Belmont, Massachusetts 02178, USA.
authors.forename: N
authors.initials: N
authors.lastname: Haque
authors.forename: O
authors.initials: O
authors.lastname: Isacson
mesh_terms: D000818:Animals; D015153:Blotting, Western; D003342:Corpus Striatum / Q000378:metabolism; D015316:Genetic Therapy; D000071058:Huntingtin Protein; D007150:Immunohistochemistry / Q000379:methods; D051379:Mice; D008815:Mice, Inbred Strains; D009410:Nerve Degeneration; D009419:Nerve Tissue Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D009422:Nervous System Diseases / Q000628:therapy*; D009687:Nuclear Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D016376:Oligonucleotides, Antisense / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013194:Staining and Labeling
chemical_list: C506812:Htt protein, mouse; D000071058:Huntingtin Protein; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins; D016376:Oligonucleotides, Antisense